Australia Recognizes Covaxin For Travel
Australia has recognized India’s Covaxin for the purpose of establishing a traveler’s vaccination status.
“Covaxin (manufactured by Bharat Biotech, India) and BBIBP-CorV (manufactured by Sinopharm, China) vaccines would be ‘recognized’ for the purpose of establishing a traveller’s vaccination status. This recognition is for travelers aged 12 and over who have been vaccinated with Covaxin, and those 18 to 60 who have been vaccinated with BBIBP-CorV,” a media release from the Australian government said.
Today, the TGA determined that Covaxin (manufactured by Bharat Biotech, India) and BBIBP-CorV (manufactured by Sinopharm, China) vaccines would be 'recognised' for the purpose of establishing a traveller's vaccination status.
Read more: https://t.co/fpQvr7FQhW pic.twitter.com/YLqIAglMQX— TGA Australia (@TGAgovau) November 1, 2021
Earlier, the Therapeutic Goods Administration (TGA) had recommended that only the vaccines approved for use in Australia, and Covishield from India and Sinovac from China be recognized for the purposes of travel and other restrictions.
Many countries have not accepted Covaxin as a valid vaccine as it has not been recognized by the WHO. Covishield is the only vaccine from India that has got approved by the WHO.
Earlier, WHO’s expert committee had revealed that the process of approval of Bharat Biotech’s Covaxin – Indigenous vaccine of India against the coronavirus disease (Covid-19) – takes longer sometimes.
